Page last updated: 2024-08-26

peptide elongation factor 2 and epidermal growth factor

peptide elongation factor 2 has been researched along with epidermal growth factor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akiyoshi, DE; Arrigo, DA; Bacha, P; Genbauffe, FS; Nichols, JC; Rhoad, AE; Shaw, JP; Sullivan, B; Thomas, J1
FitzGerald, DJ; Pastan, I; Willingham, MC1

Reviews

1 review(s) available for peptide elongation factor 2 and epidermal growth factor

ArticleYear
Pseudomonas exotoxin--immunotoxins.
    Cancer treatment and research, 1988, Volume: 37

    Topics: ADP Ribose Transferases; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Bacterial Toxins; Cross-Linking Reagents; Drug Screening Assays, Antitumor; Epidermal Growth Factor; Exotoxins; Female; Genes, Bacterial; Humans; Immunotoxins; Mice; Mice, Nude; Ovarian Neoplasms; Peptide Elongation Factor 2; Peptide Elongation Factors; Protein Engineering; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Ricin; Transferrin; Virulence Factors

1988

Other Studies

1 other study(ies) available for peptide elongation factor 2 and epidermal growth factor

ArticleYear
Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins.
    The Journal of biological chemistry, 1991, Nov-05, Volume: 266, Issue:31

    Topics: Adenosine Diphosphate Ribose; Cell Death; Diphtheria Toxin; Epidermal Growth Factor; ErbB Receptors; Escherichia coli; Genetic Engineering; Humans; In Vitro Techniques; Peptide Elongation Factor 2; Peptide Elongation Factors; Plasmids; Recombinant Fusion Proteins

1991